SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021592
Filing Date
2022-11-03
Accepted
2022-11-03 08:53:31
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20220930.htm   iXBRL 10-Q 3278359
2 EX-31.1 igms-ex31_1.htm EX-31.1 19657
3 EX-31.2 igms-ex31_2.htm EX-31.2 17928
4 EX-32.1 igms-ex32_1.htm EX-32.1 11763
5 EX-32.2 igms-ex32_2.htm EX-32.2 11743
  Complete submission text file 0000950170-22-021592.txt   8969633

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20220930_pre.xml EX-101.PRE 326182
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20220930_def.xml EX-101.DEF 214971
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20220930.xsd EX-101.SCH 53998
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20220930_lab.xml EX-101.LAB 440940
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20220930_cal.xml EX-101.CAL 43748
56 EXTRACTED XBRL INSTANCE DOCUMENT igms-20220930_htm.xml XML 1402545
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 221356430
SIC: 2834 Pharmaceutical Preparations